Keywords
Pharmacists, Aggression, healthcare settings, community pharmacies
Aggression and hostility directed at pharmacists in healthcare settings and community pharmacies are increasingly recognised as significant occupational and public health concerns. Such behaviours may negatively impact pharmacists’ psychological well-being, job satisfaction, workforce retention, and the quality and safety of patient care. Despite growing reports internationally, evidence remains fragmented, with limited synthesis across practice settings.
To map the extent, nature, contributors, and consequences of aggression and hostility against pharmacists across practice settings.
This scoping review will follow the Joanna Briggs Institute framework. Inclusion and exclusion criteria will follow the Population–Concept–Context approach. Electronic databases, along with a grey literature search, will be conducted. A data charting tool will be developed and applied through Covidence software. Qualitative and quantitative descriptive analyses will be undertaken.
Findings will inform policy, practice, and future research addressing pharmacist workplace safety.
Pharmacists, Aggression, healthcare settings, community pharmacies
Aggression and hostility directed towards healthcare professionals are widely recognised occupational hazards, with significant implications for staff wellbeing, patient safety, and workforce sustainability.1 Such behaviours may include verbal abuse, threats, intimidation, and physical violence, and are increasingly reported across healthcare systems internationally.2 Exposure to workplace aggression has been associated with adverse psychological outcomes, including stress, anxiety, burnout, reduced job satisfaction, and increased intentions to leave the profession, ultimately compromising the quality and safety of patient care.
While substantial research attention has focused on aggression experienced by nurses and physicians—particularly in emergency, psychiatric, and acute care settings—pharmacists have received comparatively limited focused investigation. This gap is notable given the evolving scope of pharmacy practice and the increasing visibility of pharmacists in both community and hospital settings. The central role of pharmacists in medication optimisation, patient counselling, chronic disease management, and the safe supply of medicines across both hospital and community settings across Ireland has evolved in recent years.3
Pharmacists frequently engage in interactions that may heighten the risk of aggressive or hostile behaviour. These include consultations involving medication access, prescription delays or refusals, opioid substitution therapy, controlled drugs, long waiting times, and encounters with patients or carers experiencing distress, pain, or frustration.3 In community settings, pharmacists are often highly accessible and may be the first point of contact for system-level pressures within primary care. In hospital environments, pharmacists work within complex, high-acuity systems where communication breakdowns and workload pressures may contribute to conflict.4 Within the Irish healthcare context, increasing service demand, workforce shortages, and expanding clinical responsibilities may further exacerbate exposure to aggression across pharmacy practice.5
Aggression and hostility towards pharmacists may have consequences extending beyond individual harm. Repeated exposure can negatively affect morale, professional engagement, and mental health, while also influencing communication with patients and colleagues. Such impacts may increase the risk of medication errors, compromise therapeutic relationships, and reduce overall quality of care.5 At an organisational level, unmanaged aggression contributes to absenteeism, reduced productivity, and workforce attrition, posing challenges to service delivery and health system resilience.
Understanding the nature, prevalence, risk factors, and consequences of aggression and hostility against pharmacists is therefore essential to inform policy development, workplace prevention strategies, education, and staff support mechanisms. However, existing evidence remains fragmented across jurisdictions, settings, and methodological approaches.6 Much of the emerging literature consists of cross-sectional studies, surveys, and national workforce or professional body reports, reflecting growing concern but lacking comprehensive synthesis.
A scoping review is an appropriate methodological approach to address this evidence gap. Scoping reviews enable systematic mapping of the breadth and characteristics of available evidence, accommodate diverse study designs, and support clarification of key concepts and definitions. This approach is particularly suitable where the evidence base is evolving and where recent empirical data require integration. An updated review is timely to incorporate new evidence, highlighting knowledge gaps, and discover future research requirements.7
An initial search of PubMed, the Cochrane Database of Systematic Reviews, PROSPERO, and the Open Science Framework registries identified no current or ongoing systematic or scoping reviews addressing aggression and hostility against pharmacists. This confirms the need for the proposed review to provide an in-depth overview of the available evidence and support policy and practice responses in Ireland and internationally. This scoping review is publicly available on the Open Science Framework (OSF) (URL: https://osf.io/cktbh/overview), to ensure transparency and reproducibility.
Sub questions:
1. What is the frequency of aggression and hostility experienced by pharmacists?
2. What forms and types of aggression (e.g., verbal abuse, physical violence, threats, intimidation) are reported?
3. Who are the perpetrators of aggression?
4. In what contexts or situations do incidents occur?
5. What are the reported psychological, professional, financial and clinical impacts of aggression on pharmacists?
6. How are incidents of aggression reported, and what strategies, policies, or interventions have been implemented to prevent or manage them and how effective are they?
7. What gaps exist in the current literature regarding aggression and hostility against pharmacists?
To provide a comprehensive mapping and synthesis of the existing literature on aggression and hostility against pharmacists in hospital and community settings.
1. To identify the types and forms of aggression and hostility experienced by pharmacists.
2. To explore the frequency of aggressive incidents reported in the literature.
3. To identify risk factors, triggers, and contextual contributors to aggression.
4. To examine the reported impacts of aggression on pharmacists’ wellbeing, professional practice.
5. To examine the reported impacts of aggression on patients/patient care.
6. To identify interventions, policies, or strategies aimed at preventing or managing aggression and their effectiveness.
7. To identify gaps in the existing evidence and guide future research needs.
This scoping review will follow the Joanna Briggs Institute (JBI) methodology for scoping reviews.8 The updated framework for scoping reviews established by Arksey & O’Malley, comprising six distinct stages, is outlined in the subsequent sections of this protocol.7 Furthermore, this review will adhere to PRISMA-ScR guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses – Scoping Review) to ensure comprehensive and transparent reporting.11
The Population, Concept, Context (PCC) framework guided the development of the review question. This is recommended for scoping reviews to facilitate broad exploration and mapping of evidence
• Population: Pharmacists
• Concept: Aggression, hostility, violence, abuse, bullying
• Context: Hospital and community pharmacy settings
The question may be refined iteratively as familiarity with the literature increases.
University librarian was consulted and a comprehensive search strategy was developed to search electronic databases,
Grey literature sources (e.g. professional reports, policy documents, theses) will also be searched. A three-step search strategy by JBI will be utilised in this review.9 The initial step started with a search of PubMed and CINAHL (EBSCO), to identify articles on the topic, and the text words and the index terms used to describe these articles were used to develop a full search strategy for searching relevant databases. An academic research librarian at the Royal College of Surgeons in Ireland (RCSI) was consulted to refine the search terms as the second step. The final step will be to review the references of key articles identified for full-text evaluation and verify that they meet the inclusion criteria. The search strategy, including all identified keywords and index terms, will be adapted for each included database and/or information source. The reference list of all included sources of evidence will be screened for additional studies.
Search terms will include combinations of keywords and subject headings related
S1: (pharmacist* OR “community pharmacist*” OR “hospital pharmacist*” OR “clinical pharmacist*” OR “pharmacy staff” OR “pharmacy personnel OR pharmacy technician”)
S2: (aggression OR hostility OR violence OR “workplace violence” OR abuse OR “verbal abuse” OR “physical violence” OR threat* OR intimidation OR assault*)
S3: (prevalence OR incidence OR frequency OR rate* OR nature OR type* OR pattern* OR characteristic* OR experience*)
S4:(“hospital pharmacy” OR “community pharmacy” OR “retail pharmacy” OR “acute care” OR “primary care”)
Inclusion criteria
- Studies involving pharmacists working in hospital or community pharmacy settings.
- Studies addressing aggression, hostility, violence, abuse, or threatening behaviour.
- Empirical research using qualitative, quantitative, or mixed-methods designs. This scoping review will include both experimental and quasi-experimental study designs, randomised and non-randomised controlled trials, prospective and retrospective cohort studies, case-control studies, and analytical cross-sectional studies. This review will also consider descriptive observational study designs, including case series, individual case reports and descriptive cross-sectional studies for inclusion. Qualitative studies such as phenomenology, grounded theory, ethnography, qualitative description, action research and feminist research study designs will also be included.
- Systematic reviews, scoping reviews, narrative reviews, integrative reviews, umbrella reviews, rapid reviews, reports, and relevant grey literature.
- Studies published in English.
- Publication date- studies published in the last 15 years (From January, 2010 – January, 2026) as many countries started implementing policies against workplace violence, with mandatory incident reporting systems and zero tolerance policies since the early 2000s, evidence published in the last 15 years will reflect current regulatory and organisational responses in this topic.
Exclusion criteria
- Studies focusing exclusively on other healthcare professionals without specific reference to pharmacists.
- Studies conducted outside hospital or community pharmacy settings (e.g. industrial or academic pharmacy only).
- Commentaries without a review method.
- Non-transparent literature overviews.
- Opinion pieces without empirical or descriptive data.
- Non-English publications.
Following the search, all identified citations will be collated and uploaded into EndNote and duplicates will be removed and exported to the Covidence software. Titles and abstracts will then be screened by two independent reviewers against the inclusion criteria for this review. The full text of selected articles against the inclusion criteria will be conducted by two independent reviewers. Reasons for exclusion of any sources after full text screening will be recorded and reported in the scoping review. Any disagreements that arise between the reviewers at any of the above stages of the selection process will be resolved through discussion or with additional input from the academic supervisors of this study. The results of the search and the study inclusion process will be reported in full in the final scoping review and presented in a PRISMA flow diagram.
Data extraction will be conducted in accordance with the JBI framework. A data-charting form will be developed and piloted within the Covidence software. The data will be coded and recorded in Covidence by one reviewer and checked by another reviewer. In line with the methodology for scoping reviews, the quality of the individual articles will be evaluated using the Joanna Briggs Institute Critical Appraisal Tools. Any disagreements that arise between the reviewers will be resolved through discussion or with an additional reviewer/s. If required, authors of papers will be contacted to request missing or additional data.
Extracted data will include:
• Author(s), year, and country
• Study aims
• Study design and methodology
• Setting (hospital or community)
• Type and definition of aggression
• Key findings related to prevalence, risk factors, impacts, and interventions and their effectiveness.
• Recommendations for practice or research & education.
The charting process will be iterative, allowing refinement as necessary.
Results will be synthesised using descriptive numerical analysis and narrative synthesis. Findings will be grouped thematically to reflect the objectives of the review. Tables and figures will be used to present the characteristics of included studies and key themes. Gaps in the literature and implications for policy, practice, and research will be highlighted. A ‘descriptive-analytical’ approach will be used. Since this is a scoping review, findings will not be statistically pooled but synthesised through descriptive numerical summaries and thematic analysis to map key concepts.
Although formal stakeholder consultation is optional in scoping reviews, consideration of key professional and workforce perspectives is important. Pharmacy unions, professional bodies, and regulatory organisations play a critical role in representing pharmacists’ interests, advocating for workplace safety, and shaping policy and organisational responses to aggression and hostility. While this review will not include direct consultation with stakeholders, the findings will be contextualised to reflect the perspectives of these organisations. Their policies, guidance documents, and position statements will be reviewed as part of the grey literature search to inform implications for practice and future research.
This scoping review will provide a comprehensive overview of the existing literature on aggression and hostility against pharmacists in hospital and community settings. The findings will inform understanding of the scope and nature of the problem, identify gaps in knowledge, and support the development of targeted interventions and policies to protect pharmacists and improve workplace safety.
This scoping review protocol is part of doctoral research conducted by the lead author. Ethical approval is not required, as the study involves the synthesis of publicly available literature and does not include primary data collection involving human participants.
No datasets have been generated or analysed at this stage, as this is a scoping review protocol. Data generated during the review, including data extraction tables and analytical outputs, will be made openly available in a recognised repository such as Zenodo under a Creative Commons Attribution 4.0 International (CC-BY) licence.
Open Science Framework: Exploring aggression and hostility against pharmacists in healthcare and community settings: a scoping review protocol. https://doi.org/10.17605/OSF.IO/CKTBH.10
The project contains the following data:
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Register with HRB Open Research
Already registered? Sign in
Submission to HRB Open Research is open to all HRB grantholders or people working on a HRB-funded/co-funded grant on or since 1 January 2017. Sign up for information about developments, publishing and publications from HRB Open Research.
We'll keep you updated on any major new updates to HRB Open Research
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)